Our findings are supported by a clinical study that reported that MR expression is lower in breast cancer compared to normal breast tissues and that MR is an independent predictor of metastasis-free survival in tamoxifen-treated breast cancer patients 67. Here, NR3C2 is linked to breast carcinoma.